ANIP - ANI Pharmaceuticals
$65.46 0.51 (0.79%)
Updated: 13:07 Apr 26, 2024 ESTNext Hour's AI Forecast
N/A
Avg. Accuracy (AI)
N/A
Next Session's AI Forecast
N/A
Avg. Accuracy (AI)
N/A
Next Week's AI Forecast
N/A
Trend's Accuracy (AI)
N/A
Rank (0-100) |
Rank (0-100) |
Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | 0 | -0.27 | 0.28 | 0.2 | 0.16 |
---|
CURRENT VOLATILITY RANK
Variation from the lowest to the highest value in a period.
Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | 0 | 0.95 | 1.33 | 1.27 | 1.51 |
---|
STOCHASTIC METRIC
The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.
Curr. Week | Next Week | Curr. Month | Curr. Quarter | N/A | N/A | 10.48% | 67.69% |
---|
MOVING AVERAGE METRIC
5 Sessions | Change 5 Sessions | 20 Sessions | Change 20 Sessions | 50 Sessions | Change 50 Sessions | 200 Sessions | 0 | -100% | 65.54 | -2.5% | 67.22 | 14.03% | 58.95 |
---|
RSI METRIC
RS Hour | RSI Hour | RS Day | RSI Day | 1.12 | 55.16 | 0.49 | 52.83 |
---|
ANI Pharmaceuticals Technical Analysis News
Mentions in the news over the last three days
In the last three days ANI Pharmaceuticals was mentioned 0 times in 1 different publications.
Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow
"Some better-ranked stocks from the healthcare industry are Ligand Pharmaceuticals (LGND Quick QuoteLGND - Free Report) , ANI Pharmaceuticals (ANIP Quick QuoteANIP - Free Report) and BridgeBio Pharma (BBIO Quick QuoteBBIO - Free Report) . While LGND sports a Zacks Rank #1 (Strong Buy), ANIP & BBIO carry a Zacks Rank #2 (Buy) each at present. You can see the complete list of today's Zacks #1 Rank stocks here."
At May 8, 2024, 1:01 pm
Zacks
ANI Pharmaceuticals
210 Main Street West
Baudette, MN 56623
United States
218 634 3500
https://www.anipharmaceuticals.com
Sectors: | Healthcare |
Industry: | Drug Manufacturers—Specialty & Generic |
F. Time Employees: | 601 |
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Corporate Governance
ANI Pharmaceuticals, Inc.’s ISS Governance QualityScore as of October 1, 2022 is 3. The pillar scores are Audit: 7; Board: 5; Shareholder Rights: 2; Compensation: 4.
List of holders with stock participation in ANI Pharmaceuticals.
Holder Rank | Holder | Shares | Date Reported | % Out | Value |
---|